Page last updated: 2024-08-23

simvastatin and ADPKD

simvastatin has been researched along with ADPKD in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angioi, A; Bergstralh, EJ; Fervenza, FC; King, BF; Larson, TS; Sethi, S; Torres, VE; Zand, L1
Alisir, S; Ecder, T; Mercanoglu, F; Namli, S; Oflaz, H; Tufan, F; Turgut, F; Ucar, A1
Blauw, GJ; Kamper, AM; Souverijn, JH; van Dijk, MA; van Veen, S1

Trials

2 trial(s) available for simvastatin and ADPKD

ArticleYear
Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016, Volume: 31, Issue:8

    Topics: Female; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Renal Circulation; Simvastatin

2016
Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16, Issue:11

    Topics: Acetylcholine; Adult; Cholesterol; Cross-Over Studies; Double-Blind Method; Female; Forearm; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Polycystic Kidney, Autosomal Dominant; Renal Circulation; Simvastatin; Vasodilation; Vasodilator Agents

2001

Other Studies

1 other study(ies) available for simvastatin and ADPKD

ArticleYear
Improvement of endothelial dysfunction with simvastatin in patients with autosomal dominant polycystic kidney disease.
    Renal failure, 2007, Volume: 29, Issue:1

    Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Simvastatin

2007